Stay updated with breaking news from Abbvie inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Through a global rights agreement with Futuregen Biopharmaceutical Co. Ltd., Abbvie Inc. continues to build its immunology portfolio to help offset losses from Humira as biosimilars tighten their grip on the mega-blockbuster. ....
Prospect Financial Services LLC purchased a new position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 1,595 shares of the company’s stock, valued at approximately $247,000. Several other institutional investors have also recently […] ....
Prospect Financial Services LLC purchased a new position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 1,595 shares of the company’s stock, valued at approximately $247,000. Several other institutional investors have also recently […] ....
Midland Wealth Advisors LLC acquired a new stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) during the 4th quarter, HoldingsChannel.com reports. The fund acquired 16,763 shares of the company’s stock, valued at approximately $2,598,000. Several other institutional investors have also added to or reduced their stakes in ABBV. EMC Capital Management purchased a […] ....
Lindsey P. Sheehan, PharmD, MPA, MBA, discusses ongoing challenges of diagnosing and treating hepatitis C, emphasizing its increased incidence among younger populations and ongoing low rates of diagnosis. ....